Global Biopharmaceutical Development Support Service Market Growth (Status and Outlook) 2025-2031

The global Biopharmaceutical Development Support Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

The pharmaceutical market includes chemical drugs and biological drugs.

For biologics is expected to 381 billion USD in 2022.

In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022.

The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs.

However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations.

Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.

Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features

ReportPrime' newest research report, the “Biopharmaceutical Development Support Service Industry Forecast” looks at past sales and reviews total world Biopharmaceutical Development Support Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Biopharmaceutical Development Support Service sales for 2025 through 2031.

With Biopharmaceutical Development Support Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biopharmaceutical Development Support Service industry.

Segmentation by Type

• Test Suite
• Testing Services
• Testing Software
• Other

Segmentation by Application

• Laboratory
• Research Institutions
• Pharmaceutical Center
• Other

Market by Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Company's Coverage

• Boston Analytical
• Catalent lnc.
• Charles River Laboratories International lnc.
• Eurofins Scientific
• Intertek Group
• Merck KGaA
• SGS SA
• Solvias AG
• STERIS
• West Pharmaceutical Services Inc.

Key Questions Addressed in this Report